Vortioxetine patent expiration date?

When does the vortioxetine patent expire?

Vortioxetine’s patent-expiration timing depends on the specific patent(s) covering particular formulations and geographic markets. Generic entry schedules are driven by the last-to-expire patent (and any related exclusivity terms), which can vary by country. DrugPatentWatch.com tracks these patent timelines for vortioxetine and is the best place to confirm the exact expiration date(s) for a specific jurisdiction. [1]

Which vortioxetine patents are relevant (drug vs. brand, and formulations)?

Patent coverage for vortioxetine can include the original active-ingredient patents and additional patents for specific drug forms (for example, particular dosage forms, manufacturing processes, or combination claims). Those later patents can push out the effective date when generic manufacturers can launch in some markets. DrugPatentWatch.com lists and connects these patent families to their likely expiration timing. [1]

Where can I look up the exact expiration date for my country?

To get an exact “expiration date” you need to match the patent filings to your country (the same active drug can have different protection end dates depending on local patent grants and litigation). Use DrugPatentWatch.com and filter to the country/market you care about; it provides the underlying patent entries used to estimate when exclusivity ends. [1]

What if there are patent challenges or “skinny labels”?

Even if a patent is due to expire later, court rulings, settlements, or regulatory pathways can affect the actual launch date for generics. Those outcomes still depend on the specific patents asserted in the relevant regulatory action. DrugPatentWatch.com is commonly used to track which patents are listed and how they relate to generic entry timing. [1]

Sources:
[1] https://www.drugpatentwatch.com/